Immunology/Inflammation
Read More about this categoryShow Less
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Research Areas
- 5-Lipoxygenase(17)
- Apoptosis(908)
- Cyclic GMP-AMP Synthase(7)
- TLR(138)
- Papain(1)
- PGDS(1)
- PGE synthase(26)
- SIKs(13)
- IκB/IKK(72)
- AP-1(15)
- KEAP1-Nrf2(65)
- NOD1(1)
- NF-κB(335)
- Interleukin Related(363)
- 15-lipoxygenase(2)
- Others(10)
- Aryl Hydrocarbon Receptor(43)
- CD73(18)
- Complement System(83)
- Galectin(14)
- IFNAR(72)
- NO Synthase(108)
- NOD-like Receptor (NLR)(77)
- STING(125)
- Reactive Oxygen Species(554)
- FKBP(17)
- eNOS(4)
- iNOS(29)
- nNOS(20)
- Glutathione(54)
- Adaptive Immunity(210)
- Allergy(118)
- Arthritis(34)
- Autoimmunity(181)
- Gastric Disease(95)
- Immunosuppressants(38)
- Immunotherapeutics(4)
- Innate Immunity(566)
- Pulmonary Diseases(110)
- Reactive Nitrogen Species(50)
- Specialized Pro-Resolving Mediators(49)
- Reactive Sulfur Species(28)
- BCL6(9)
- CD20(15)
- CD22(2)
- CD28(10)
- PSMA(17)
- FAP(27)
- Nuclear Factor of activated T Cells (NFAT)(3)
- Glycoprotein VI(2)
- Tim3(6)
- Hapten(1)
- Nectin-4(3)
- DOCK(4)
- MHC(15)
- Transmembrane Glycoprotein(54)
- TREM receptor(14)
- Inflammation or Immune System Disease(2)
- Musculoskeletal and Skin Disease(1)
- Fc Receptor (FcR)(16)
- IKZF Family(5)
- C-type Lectin-like Receptors (CTLRs)(13)
- Asialoglycoprotein Receptor (ASGPR)(3)
- Human leukocyte immunoglobulin (Ig)-like receptors (LILR)(1)
Products Related to Immunology/Inflammation(4970)
- GC70296DaclizumabCAS: 152923-56-3Purity: >99.50%
Daclizumab (Zenapax) 는 CD25(고친화력 백혈구 매개체-2 수용체(IL-2R-HA)의 알파아키아)를 차단하는 인적 유래 단일 클론 항체이다.
- GC70411Nrf2-Activator-12GCAS: 1554271-18-9Purity: >99.00%
Nrf2-Activator-12G (compd 12g) 는 Nrf2의 활성제입니다.
- GC70480Simvastatin acid calcium hydrateCAS: 530112-57-3
Simvastatin acid calcium hydrate은 강력한 HMG-CoA 환원효소(HMGCR) 억제제다.
- GC70733ABT-510 acetateCAS: 442526-87-6Purity: >99.00%
ABT-510 acetate 는 상피성 난소암 원위동유전자 모델에서 세포의 사멸을 유도하고 난소종양의 성장을 억제하는 항혈관생성 TSP펩타이드(혈소판반응단백질-1 유사물)의 일종이다.
- GC70768BMS-986251CAS: 2460133-35-9
BMS-986251 는 경구 활성 및 선택적 ROR 감마 t 역방향 흥분제로서 ROR 감마 t-GAL4의 EC50은 12 nM입니다.
- GC70853Broussochalcone ACAS: 99217-68-2Purity: >97.00%
Broussochalcone A은 항 산화제와 Xanthine의 억제 Oxidase (IC50 = 2 μ M) 21, 무료로 급진적인 청소 활동이다.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC70296 | Daclizumab | 152923-56-3 | >99.50% | |
Daclizumab (Zenapax) 는 CD25(고친화력 백혈구 매개체-2 수용체(IL-2R-HA)의 알파아키아)를 차단하는 인적 유래 단일 클론 항체이다. | ||||
| GC70298 | Peginterferon beta-1a | 1211327-92-2 | - | |
Peginterferon β-1a는 최초의 페질화된 인터페론 베타-1a 분자이다. | ||||
| GC70300 | Rilonacept | 501081-76-1 | - | |
이종 융합 단백질인 Rilonacept (Arcalyst)는 인터류킨 1억제제다. | ||||
| GC70388 | Justicidin B | 17951-19-8 | >99.00% | |
Justicidin B 는 강력한 항암 나프타와 시체 촉진제이다. | ||||
| GC70411 | Nrf2-Activator-12G | 1554271-18-9 | >99.00% | |
Nrf2-Activator-12G (compd 12g) 는 Nrf2의 활성제입니다. | ||||
| GC70418 | Cipepofol | 1637741-58-2 | >98.00% | |
Cipepofol (Ciprool) 는 페놀 유도체를 대체하는 새로운 2,6-2 종으로, GABAA 수용체의 양변조 조절제이자 직접 흥분제이다. | ||||
| GC70477 | Phox-I2 | 353495-22-4 | >99.00% | |
Phox-I2 는 p67phox-Rac1 상호작용의 선택적 억제제로서 p67phox와 높은 친화력으로 결합하여 Kd는 약 150nM이다. | ||||
| GC70480 | Simvastatin acid calcium hydrate | 530112-57-3 | - | |
Simvastatin acid calcium hydrate은 강력한 HMG-CoA 환원효소(HMGCR) 억제제다. | ||||
| GC70485 | Celiprolol-d9 hydrochloride | 1215535-20-8 | - | |
Celiprolol-d9 hydrochloride 는 듀테륨 표기 염산셀리롤이다. | ||||
| GC70520 | MIND4-17 | 345989-24-4 | >99.00% | |
MIND4-17 Keap1의 C151 잔기를 공가로 수식하는 강력한 NRF2 활성제입니다. | ||||
| GC70567 | NecroX-7 | 1120332-55-9 | >99.00% | |
NecroX-7 는 강력한 자유 기반 제거제 및 HMGB1 (고이동률 패밀리 박스 1) 억제제입니다. | ||||
| GC70570 | RH01386 | 301177-36-6 | >99.00% | |
RH01386 는 내질망 스트레스 (ERS) 가 유도하는 베타세포 기능 장애와 사멸을 예방하고 사멸 촉진 유전자의 발현을 억제하는 소분자다. | ||||
| GC70571 | CP-312 | 895470-67-4 | >99.00% | |
CP-312 는 강력한 헤모글로빈 산소 효소-1 (HO-1) 유도제입니다. | ||||
| GC70584 | Actinomycin X2 | 18865-48-0 | >98.00% | |
Actinomycin X2 (방선균소 V), 많은 스트렙토마이신에서 생성됩니다. | ||||
| GC70612 | Arochlor 1254 | 11097-69-1 | - | |
Arochlor 1254는 비페닐과 54% 염소가있는 폴리염화비페닐 (PCB) 혼합물이다. | ||||
| GC70659 | 9-cis-Retinoic acid-d5 | - | >98.00% | |
9-cis-Retinoic acid-d5 는 듀테륨 표기의 9-순식 비갑산이다. | ||||
| GC70733 | ABT-510 acetate | 442526-87-6 | >99.00% | |
ABT-510 acetate 는 상피성 난소암 원위동유전자 모델에서 세포의 사멸을 유도하고 난소종양의 성장을 억제하는 항혈관생성 TSP펩타이드(혈소판반응단백질-1 유사물)의 일종이다. | ||||
| GC70742 | Betamethasone-d5-1 | 2244574-92-1 | - | |
βmethasone-d5-1 듀테륨은 배타미송으로 표기되어 있다. | ||||
| GC70753 | PDK4-IN-1 | 2310262-10-1 | >98.00% | |
PDK4-IN-1 는 안트라키논 유도체이자 강력한 경구 활성 아세톤산 탈수소 효소 효소 4 (PDK4) 억제제로서 IC50 값은 84nM입니다. | ||||
| GC70756 | Cytarabine-d2 | 40632-26-6 | >98.00% | |
Cytarabine-d2 는 듀테륨 표기의 아당포닌이다. | ||||
| GC70759 | AQX-435 | 1619983-52-6 | >99.00% | |
AQX-435 는 강력한 SHIP1 인산 효소 활성화제입니다. | ||||
| GC70768 | BMS-986251 | 2460133-35-9 | - | |
BMS-986251 는 경구 활성 및 선택적 ROR 감마 t 역방향 흥분제로서 ROR 감마 t-GAL4의 EC50은 12 nM입니다. | ||||
| GC70787 | β-Aminoarteether | 133162-24-0 | - | |
β-Aminoarteether (SM934 유리알칼리) 는 경구 활성을 가진 아르테미시닌 파생물이다. | ||||
| GC70853 | Broussochalcone A | 99217-68-2 | >97.00% | |
Broussochalcone A은 항 산화제와 Xanthine의 억제 Oxidase (IC50 = 2 μ M) 21, 무료로 급진적인 청소 활동이다. | ||||
